Prof. Suresh Mickymaray: Nanobiotechnology: Best Researcher Award
Prof. Suresh Mickymaray, Majmaah University, Saudi Arabia
📅 Career Overview:
Associate Professor: Microbiology, College of Science, Majmaah University, Saudi Arabia (Sep 2020 – Present). Distinguished Adjunct Professor: Centre of Molecular Medicine and Diagnostics, Saveetha University, India (Jan 2022 – Present). Assistant Professor: Microbiology, Majmaah University, Saudi Arabia (Jun 2016 – Aug 2020). Assistant Professor: Medical Laboratories, Majmaah University, Saudi Arabia (Aug 2014 – Jun 2016). Head: Microbiology & Molecular Biology, Doctors’ Diagnostic Center, Trichy, India (2012 – Aug 2014). Assistant Professor: Urumu Dhanalakshmi College, Trichy, India (Oct 2010 – Jan 2012). Research Scholar: A.V.V.M Sri Pushpam College, Thanjavur, India (Jun 2006 – Oct 2010). Microbiologist: Doctors’ Diagnostic Centre, Trichy, India (Apr 2004 – May 2006). Associate Microbiologist: Seahorse Hospitals Ltd., Trichy, India (1993 – Jun 2004).
The impact of her research is evident in citation metrics and indices from Google Scholar:
- Cited by: All – 1,046.
- Citations – 938.
- h-index – 15.
- Documents – 39.
A prolific researcher making meaningful contributions to the academic world!
Research Focus: 🧬
Prof. Suresh Mickymaray stands as a prominent figure in the scientific community, particularly excelling in the fields of Medicinal Nanoparticles and Antimicrobial Agents. His groundbreaking work includes the synthesis of gold nanoparticles from Catharanthus roseus, cited 377 times in 2019, demonstrating its potential in inducing caspase-mediated apoptosis in cervical cancer cells (HeLa). His impactful contributions extend to the exploration of flavonoids, with a focus on their anti-fungal efficacy and mechanisms, cited by 268 in 2020. Prof. Mickymaray’s research portfolio encompasses the evaluation of traditional medicinal plants and bioactive compounds against clinically important pathogens, earning 133 citations in 2019. In the realm of cancer research, his work on Rhaponticin’s suppression of osteosarcoma through the inhibition of the PI3K-Akt-mTOR pathway, cited 57 times in 2021, reflects his dedication to advancing therapeutic strategies against cancer. Prof. Suresh Mickymaray’s extensive contributions epitomize his commitment to advancing scientific knowledge for the betterment of healthcare. 🌐🔬